Key takeaways:
- Early detection and accurate diagnosis are essential for optimising clinical management and improving outcomes in patients with amyloidosis
- The National Amyloidosis Centre has a range of advanced diagnostic techniques to confirm the presence of amyloidosis in a person
- Investigations may include SAP scintigraphy, cardiac MRI scans, DPD scans and genetic testing
- Accurate subtyping enables tailored therapeutic strategies, which are key to effective disease management
Speakers
Emily Dixon, Principal Genetic Counsellor
Darren Foard, Lead AL Amyloidosis Clinical Nurse Specialist
Professor Philip Hawkins, Consultant Physician; Clinical Director; Founder of NAC
David Hutt, Lead Nuclear Medicine Technologist
Dr Ana Martinez Naharro, Consultant Cardiologist
Dr Tamer Rezk, Consultant Nephrologist
Dr Dorota Rowczenio, Head of Genetic Service
Angelique Smit, Lead Clinical and Research Nurse